Biophysical constraints of influenza neuraminidase evolution
流感神经氨酸酶进化的生物物理限制
基本信息
- 批准号:10654846
- 负责人:
- 金额:$ 51.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-28 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Amino Acid SubstitutionAmino AcidsAntibodiesAttentionBiochemicalBiological AssayBiologyBiophysical ProcessBiophysicsCessation of lifeDataDevelopmentEffectivenessEvolutionGeneticGenetic EpistasisGlycoproteinsGoalsHemagglutininHumanImmunityIndividualInfectionInfluenzaInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza A virusInfluenza HemagglutininKnowledgeMapsMeasuresMolecularMutationNeuraminidasePathway interactionsPlayPopulationProteinsPublic HealthResearchRoleShapesStatistical ModelsSurfaceSurface AntigensUpdateVaccinesViralViral ProteinsVirus Replicationbiophysical modelbiophysical propertiesexperimental studyfitnessglobal healthinfluenza epidemicinfluenza virus straininfluenza virus vaccineinfluenzavirusinnovationinsightinterdisciplinary approachinterestmutantmutation screeningnext generationporcine modelseasonal influenzastructural biologytransmission processvaccine developmentviral fitness
项目摘要
PROJECT SUMMARY
Seasonal influenza epidemic causes 3-5 million infections and 250,000 to 500,000 deaths every year. While
seasonal influenza vaccine is available and being constantly updated, its effectiveness is often hampered by
the rapid antigenic drift of circulating strains. As a result, a major goal of influenza research is to develop a
more effective vaccine. Nevertheless, the poor ability to forecast the evolution of influenza virus poses a huge
challenge in influenza vaccine development. Consequently, understanding how the evolutionary trajectories of
influenza virus are being shaped can significantly benefit public health. Influenza virus has two surface
antigens, namely hemagglutinin (HA) and neuraminidase (NA). While influenza vaccine development has
traditionally focused on targeting the HA, NA has received increasing attention as an effective vaccine target in
recent years. Evolution of NA is under several biophysical constraints including protein stability, surface
expression, and enzymatic activity. These biophysical constraints determine not only the fitness effects of
individual mutations, but also how these fitness effects vary in the presence of other mutations (i.e. epistasis).
In fact, epistasis has been a main obstacle in evolution forecast since epistasis can lead to opposite fitness
effects of the same mutation in different influenza strains. This proposed study will use innovative high-
throughput experiments to systematically probe the fitness effects of all possible amino-acid mutations on NA
and map epistatic interactions that are involved in the natural evolution of NA. In addition, the molecular
mechanisms of epistasis will be characterized by biochemical and structural biology approaches. Statistical
modeling will further be applied to quantify the relationships between biophysical constraints of NA and viral
fitness. The results will comprehensively reveal the biophysical principles that govern the mutational fitness
effects and epistatic interactions in influenza NA, and hence its evolutionary trajectories in natural evolution.
This proposed study will therefore promote the construction of a unifying biophysical model to accurately
forecast the evolution of influenza virus, which will in turn facilitate the development of next-generation
influenza vaccines.
项目摘要
季节性流感流行病每年引起3-500万感染和250,000至500,000人死亡。尽管
可以使用季节性流感疫苗并不断更新,其有效性通常受到阻碍
循环菌株的快速抗原漂移。结果,流感研究的主要目标是开发
更有效的疫苗。然而,预测流感病毒演变的不良能力构成了巨大的
流感疫苗开发中的挑战。因此,了解如何的进化轨迹
正在形成流感病毒可以极大地使公共卫生受益。流感病毒有两个表面
抗原,即血凝素(HA)和神经氨酸酶(NA)。而流感疫苗的开发有
传统上专注于针对HA,NA作为有效的疫苗目标受到了越来越多的关注
近年来。 Na的演变在几种生物物理约束下,包括蛋白质稳定性,表面
表达和酶活性。这些生物物理约束不仅决定了
个体突变,但这些适应性在存在其他突变(即上毒)的情况下会有所不同。
实际上,上毒一直是进化预测的主要障碍
在不同流感菌株中相同突变的影响。这项拟议的研究将使用创新的高
吞吐量实验,以系统地探测所有可能的氨基酸突变对Na的适应性影响
以及与Na的自然演化有关的MAP上的同义相互作用。另外,分子
上位性的机制将以生化和结构生物学方法为特征。统计
建模将进一步应用来量化Na和病毒的生物物理约束之间的关系
健康。结果将全面揭示控制突变适应性的生物物理原理
流感NA中的影响和上毒相互作用,因此在自然进化中的进化轨迹。
因此,这项拟议的研究将促进统一的生物物理模型的构建以准确
预测流感病毒的演变,这反过来又有助于下一代发展
流感疫苗。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mutational fitness landscape of human influenza H3N2 neuraminidase.
- DOI:10.1016/j.celrep.2022.111951
- 发表时间:2023-01-31
- 期刊:
- 影响因子:8.8
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas C. Wu其他文献
Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza Ha stem
针对流感 Ha 干细胞的 IGHV1-69 广泛中和抗体的严格且复杂的序列限制
- DOI:
10.1016/j.celrep.2023.113410 - 发表时间:
2023 - 期刊:
- 影响因子:8.8
- 作者:
Qi Wen Teo;Yiquan Wang;Huibin Lv;Timothy J. C. Tan;R. Lei;Kevin J. Mao;Nicholas C. Wu - 通讯作者:
Nicholas C. Wu
Membrane binding is involved in the action of broadly neutralizing influenza antibodies
- DOI:
10.1016/j.bpj.2022.11.2418 - 发表时间:
2023-02-10 - 期刊:
- 影响因子:
- 作者:
Defne Gorgun;Timothy James Tan;Po-Chao Wen;Martin Frank;Zhaleh Ghaemi;Nicholas C. Wu;Emad Tajkhorshid - 通讯作者:
Emad Tajkhorshid
Comparing absolute numbers of Glua1 and Glua2 in hippocampal neurons through qPAINT
- DOI:
10.1016/j.bpj.2023.11.1049 - 发表时间:
2024-02-08 - 期刊:
- 影响因子:
- 作者:
Gloria W. Lau;Max Winga;Timothy James Tan;Ruipeng Lei;Hee Jung Chung;Nicholas C. Wu;Paul R. Selvin - 通讯作者:
Paul R. Selvin
A library-on-library screen reveals the breadth expansion landscape of a broadly neutralizing betacoronavirus antibody
文库上的文库筛选揭示了广泛中和β冠状病毒抗体的广度扩展前景
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Marya Y. Ornelas;Wenhao O. Ouyang;Nicholas C. Wu - 通讯作者:
Nicholas C. Wu
Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit
与 H3 流感血凝素、HA1 亚基结合的 C05 V110P/A117E 突变体的晶体结构
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
A. M. Sevy;Nicholas C. Wu;Iuliia M. Gilchuk;Erica H Parrish;Sebastian Burger;Dina Yousif;Marcus B. M. Nagel;K. Schey;Ian A. Wilson;James E. Crowe;Jens Meiler - 通讯作者:
Jens Meiler
Nicholas C. Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas C. Wu', 18)}}的其他基金
Sequence-function relationship of influenza broadly neutralizing antibodies
流感广泛中和抗体的序列-功能关系
- 批准号:
10415666 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Sequence-function relationship of influenza broadly neutralizing antibodies
流感广泛中和抗体的序列-功能关系
- 批准号:
10555301 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Sequence-function relationship of influenza broadly neutralizing antibodies
流感广泛中和抗体的序列-功能关系
- 批准号:
10898173 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Biophysical constraints of influenza neuraminidase evolution
流感神经氨酸酶进化的生物物理限制
- 批准号:
10522548 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
High-throughput identification of antibody features for sequence-based epitope prediction
高通量鉴定抗体特征以进行基于序列的表位预测
- 批准号:
10243575 - 财政年份:2021
- 资助金额:
$ 51.23万 - 项目类别:
MECHANISTIC UNDERSTANDING OF INFLUENZA-HOST INTERACTIONS FROM A ZOONOTIC PERSPECTIVE
从人畜共患病的角度理解流感-宿主相互作用的机制
- 批准号:
10217310 - 财政年份:2019
- 资助金额:
$ 51.23万 - 项目类别:
MECHANISTIC UNDERSTANDING OF INFLUENZA-HOST INTERACTIONS FROM A ZOONOTIC PERSPECTIVE
从人畜共患病的角度理解流感-宿主相互作用的机制
- 批准号:
10242968 - 财政年份:2019
- 资助金额:
$ 51.23万 - 项目类别:
相似国自然基金
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:32202823
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
聚氨基酸用于蛋白质翻译后修饰泛抗体的诱导与制备
- 批准号:22105008
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于非天然氨基酸光交联的表位靶向抗体筛选及其应用研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
磷酸化组氨酸(pHis)的抗体富集、质谱鉴定及生物功能研究
- 批准号:91953103
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:重大研究计划
相似海外基金
Impacts of Adaptive Coronavirus Evolution on Viral Membrane Fusion
冠状病毒适应性进化对病毒膜融合的影响
- 批准号:
10727448 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Serogroup 19 capsule maleability leading to vaccine failure
血清群 19 胶囊的雄性能力导致疫苗失败
- 批准号:
10723991 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Defining the Interplay Between Viral Adaptation and Host Proteostasis
定义病毒适应和宿主蛋白质稳态之间的相互作用
- 批准号:
10587055 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Biophysical constraints of influenza neuraminidase evolution
流感神经氨酸酶进化的生物物理限制
- 批准号:
10522548 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Defining the Interplay Between Viral Adaptation and Host Proteostasis
定义病毒适应和宿主蛋白质稳态之间的相互作用
- 批准号:
10707348 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别: